Publication: 3082

Publication: 3082

Alliance A091404: a phase II study of enzalutamide (nsc# 766085) for patients with androgen receptor positive salivary cancers

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 37 (15_suppl) 6020-6020

Meeting Instance:: ASCO 2019
Year:: 2019
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3705

Program:: OGC
Primary Committee:: Experimental
Sec. Committees:

Pharmas:: Astellas
Grants:: U10CA180821, U10CA180882, U10CA180868 (NRG); U10CA180888 (SWOG);

Corr. Author:
Authors:: Alan Loh Ho Nathan R. Foster Alex J. Zoroufy Francis Worden Katharine Price Douglas Adkins Daniel W. Bowles Hyunseok Kang Barbara Burtness Eric Sherman Roscoe Morton Nora Katabi Pamela Munster Gary K. Schwartz

Networks:: CA824, COLUMBIA, IWORC, LAPS-CO070, LAPS-CT018, LAPS-MN026, LAPS-MO011, LAPS-NY016, MI014

Study: Alliance-A091404
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: